PURPOSE: To compare the efficacy of autologous cell therapy after irradiation combined with granulocyte-colony stimulating factor (G-CSF) injections with G-CSF treatment alone in a heterogeneous model of irradiation representative of an accidental situation. MATERIAL AND METHODS: Non-human primates were irradiated at 8.7 Gy whole-body dose with the right arm shielded to receive 4.8 Gy. The first group of animals received G-CSF (lenograstim) injections starting 6 h after irradiation, and a second group received a combination of G-CSF (lenograstim) injections and autologous expanded hematopoietic cells. Animals were followed up for blood cell counts, circulating progenitors, and bone marrow cellularity. RESULTS: No significant differences were seen between the two treatment groups, whatever the parameter observed: time to leukocyte or platelet recovery and duration and severity of aplasia. CONCLUSION: Our results indicated that identical recovery kinetic was observed when irradiated animals are treated with G-CSF independently of the reinjection of ex vivo expanded autologous hematopoietic cells. Thus G-CSF injections might be chosen as a first-line therapeutic strategy in the treatment of accidental acute radiation victims.
PURPOSE: To compare the efficacy of autologous cell therapy after irradiation combined with granulocyte-colony stimulating factor (G-CSF) injections with G-CSF treatment alone in a heterogeneous model of irradiation representative of an accidental situation. MATERIAL AND METHODS: Non-human primates were irradiated at 8.7 Gy whole-body dose with the right arm shielded to receive 4.8 Gy. The first group of animals received G-CSF (lenograstim) injections starting 6 h after irradiation, and a second group received a combination of G-CSF (lenograstim) injections and autologous expanded hematopoietic cells. Animals were followed up for blood cell counts, circulating progenitors, and bone marrow cellularity. RESULTS: No significant differences were seen between the two treatment groups, whatever the parameter observed: time to leukocyte or platelet recovery and duration and severity of aplasia. CONCLUSION: Our results indicated that identical recovery kinetic was observed when irradiated animals are treated with G-CSF independently of the reinjection of ex vivo expanded autologous hematopoietic cells. Thus G-CSF injections might be chosen as a first-line therapeutic strategy in the treatment of accidental acute radiation victims.
Authors: Chris Wambi; Jenine Sanzari; X Steven Wan; Manunya Nuth; James Davis; Ying-Hui Ko; Carly M Sayers; Matthew Baran; Jeffrey H Ware; Ann R Kennedy Journal: Radiat Res Date: 2008-04 Impact factor: 2.841
Authors: Douglas V Faller; Serguei A Castaneda; Daohong Zhou; Merriline Vedamony; Peter E Newburger; Gary L White; Stanley Kosanke; P Artur Plett; Christie M Orschell; Michael S Boosalis; Susan P Perrine Journal: Blood Cells Mol Dis Date: 2016-10-31 Impact factor: 3.039
Authors: Vadim I Krivokrysenko; Alexander N Shakhov; Vijay K Singh; Frederick Bone; Yevgeniy Kononov; Inna Shyshynova; Alec Cheney; Ratan K Maitra; Andrei Purmal; Mark H Whitnall; Andrei V Gudkov; Elena Feinstein Journal: J Pharmacol Exp Ther Date: 2012-07-26 Impact factor: 4.030
Authors: Thomas J MacVittie; Alexander Bennett; Catherine Booth; Michael Garofalo; Gregory Tudor; Amanda Ward; Terez Shea-Donohue; Daniel Gelfond; Emylee McFarland; William Jackson; Wei Lu; Ann M Farese Journal: Health Phys Date: 2012-10 Impact factor: 1.316
Authors: Ann M Farese; Cassandra R Brown; Cassandra P Smith; Allison M Gibbs; Barry P Katz; Cynthia S Johnson; Karl L Prado; Thomas J MacVittie Journal: Health Phys Date: 2014-01 Impact factor: 1.316
Authors: Somaiah Chinnapaka; Katherine S Yang; Yasamin Samadi; Michael W Epperly; Wen Hou; Joel S Greenberger; Asim Ejaz; J Peter Rubin Journal: Stem Cells Transl Med Date: 2021-03-16 Impact factor: 6.940